SpindleCommunications partners with clients on strategic communications programs –
including strategy and brand positioning, corporate communications, as well as
public and investor relations to life science, pharmaceutical, medical device
and diagnostics and clean and renewable technologies clients.
At
Spindle Communications, our objective is to make our clients better known,
better regarded and more successful through effective public relations,
marketing communications and investor relations.
We
translate the science into stories that resonate with broad audiences by
working with all the parties concerned, being the researchers, patients
and with the media.
From discovery
to development to commercialization, Spindle is uniquely able to provide its
services to a broad range of life sciences firms. Biotechnology start-ups are
measured and evaluated by more than financial parameters. The right
communications strategy and tactical execution can greatly impact how well a
young company makes its initial impressions on potential investors, partners,
customers, as well as regulatory authorities.
We are
dedicated to giving clients in the healthcare and life science industries a
clear advantage in a competitive marketplace. Whether placing news stories
covering the launch of new research initiatives, investor events, current
testing and trials, newsworthy approvals, exciting mergers and acquisitions,
new funding/investment rounds, confidence-building staff announcements,
profit reports, and also crisis management, generating consistent and positive
exposure is essential for ensuring that media effort for the company is well
thought and executed.
The
benefits:
Gaining
investor confidence and appeal as an investment destination for venture
capitalists and private equity funders. The duration and the resources required
to bring about a product, technology, or service into the market are
significant and thus investor fatigue usually sets in long before the company
arrives at the finish line. Sustainable PR/IR can and will reduce the
volatility in the perceived risk associated with company and its
product/technology
Importantly
it may very well allow existing investors to trade in their shareholding of the
company in a more liquid market and hence reduce a drop in company.
Last but
not least a well structured and executed PR/IR program will allow the company
to embark on fund raising at its discretion and make the offering at a higher
premium than otherwise would have been the case.
Ultimately, life science public relations is the lifeblood for attaining
funding for scientific breakthroughs and profitability.
Spindle Communications focuses on building a company's reputation with the
press and industry opinion leaders, establishing credibility and building
lasting relationships. Whether introducing a new genetic test, creating
awareness of an illness that a healthcare or pharmaceutical company is seeking
a new and formidable medicinal arsenal to fight with, proving to consumers and
regulatory bodies that a new technology is safe and ethical, or building media
mindshare and market acceptance, successful marketing communications
practitioners and programs must be able to look near and beyond the horizon.
Much of the company’s present and future may be dependent on clearly defined
set of marketing and PR objectives, so is the deployment of these objectives
being done proficiently and competitively.
Just as superior science provides the competitive advantage for
pharmaceutical and biotech companies, choosing the right life sciences PR
agency can be the critical difference between marketing failure and success.
Spindle has perfected the science and art of media relations and
orchestrates national and cross-border PR/IR campaigns that achieve objectives
such as product and technology visibility, partnership and funding cultivation,
clinical trial recruitment, pre-launch market conditioning, new product
introductions, reimbursement advocacy, alliance-building and paving the way for
successful liquidity event.
Spindle has a track record of working with some of the most innovative
companies in the life sciences sector to publicize their science, products and
people.
Our focus falls on biotech, pharma, medtech, diagnostics and
healthcare public relations, marketing and investor relations services.
